Adrenaline infusion
adrenaline epinephrine infusion dosing indications
adrenaline infusion preparation administration ICU vasopressor
| Dose | Dominant Receptors | Key Effects |
|---|---|---|
| Low (< 0.05 mcg/kg/min) | β1, β2 | ↑ HR, ↑ contractility, ↓ SVR (vasodilation) |
| Moderate (0.05–0.2 mcg/kg/min) | β1 > α1 | ↑ HR, ↑ contractility, mixed vascular effect |
| High (> 0.2 mcg/kg/min) | α1 dominant | ↑↑ SVR (vasoconstriction), ↑ BP |
| Indication | Starting Dose | Usual Range |
|---|---|---|
| Septic shock (adjunct) | 0.05 mcg/kg/min | 0.05–0.5 mcg/kg/min |
| Cardiogenic shock | 0.05–0.1 mcg/kg/min | 0.05–0.3 mcg/kg/min |
| Post-arrest | 0.1 mcg/kg/min | 0.05–0.5 mcg/kg/min |
| Anaphylaxis (infusion) | 0.05–0.1 mcg/kg/min | Titrated to MAP |
Rate (mL/hr) = [Dose (mcg/kg/min) × Weight (kg) × 60] ÷ Concentration (mcg/mL)
(0.1 × 70 × 60) ÷ 80 = 5.25 mL/hr
| Effect | Mechanism |
|---|---|
| Tachycardia / arrhythmias | β1 stimulation |
| Hypertension | α1 stimulation |
| Myocardial ischaemia | ↑ O₂ demand + coronary vasospasm |
| Hyperlactatemia | β2-mediated glycogenolysis (not always ischaemic) |
| Hyperglycaemia | Hepatic glucose production |
| Hypokalaemia | β2-mediated K⁺ shift |
| Tissue necrosis (extravasation) | Local α1-mediated vasoconstriction |
| Pulmonary oedema | ↑ preload + afterload mismatch |
4 mg how many ampoules
| Ampoule | Concentration | Adrenaline per ampoule |
|---|---|---|
| 1 mL ampoule | 1:1,000 (1 mg/mL) | 1 mg |
| 10 mL ampoule | 1:10,000 (0.1 mg/mL) | 1 mg |